URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Anton Porsteinsson

Concepts (212)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Alzheimer Disease
31
1997
294
4.840
Why?
Dementia
8
1997
102
2.660
Why?
Valproic Acid
9
1997
54
2.110
Why?
Psychomotor Agitation
9
1997
43
1.680
Why?
Mental Disorders
7
1996
347
1.430
Why?
Amyloid beta-Peptides
4
2011
57
1.230
Why?
Memantine
2
2007
13
1.210
Why?
Excitatory Amino Acid Antagonists
2
2007
38
1.190
Why?
Receptors, N-Methyl-D-Aspartate
3
2003
84
1.180
Why?
Aged
38
1996
7269
1.060
Why?
Cholinesterase Inhibitors
5
2000
20
1.040
Why?
Serotonin Uptake Inhibitors
6
2002
34
1.020
Why?
Cognition Disorders
8
2008
286
0.980
Why?
Aging
2
2009
707
0.950
Why?
Peptide Fragments
3
2011
282
0.930
Why?
Sertraline
5
2006
9
0.910
Why?
Neuropsychological Tests
8
2000
386
0.880
Why?
Depressive Disorder, Major
3
1997
164
0.800
Why?
Aged, 80 and over
20
1996
2529
0.720
Why?
Psychotropic Drugs
4
1997
38
0.700
Why?
Double-Blind Method
14
2000
992
0.680
Why?
Depression
7
2001
432
0.560
Why?
Humans
43
1996
36274
0.530
Why?
Female
31
1996
19838
0.510
Why?
Male
30
1996
19675
0.490
Why?
Neuroprotective Agents
5
2002
119
0.460
Why?
Depressive Disorder
4
2006
318
0.440
Why?
Antimanic Agents
2
2001
8
0.420
Why?
Enzyme Inhibitors
2
2003
422
0.410
Why?
Antibodies, Monoclonal, Humanized
2
2012
87
0.410
Why?
Severity of Illness Index
5
2000
922
0.390
Why?
Psychotic Disorders
3
2003
67
0.370
Why?
Treatment Outcome
12
2000
2615
0.360
Why?
Activities of Daily Living
4
2000
261
0.360
Why?
Antidepressive Agents
2
2010
93
0.350
Why?
Drug Therapy, Combination
3
1997
382
0.350
Why?
Anticonvulsants
4
2001
122
0.330
Why?
Mental Status Schedule
5
2005
32
0.330
Why?
Cognition
3
2000
227
0.320
Why?
Middle Aged
14
1996
9837
0.320
Why?
Dose-Response Relationship, Drug
6
2000
1117
0.310
Why?
Antipsychotic Agents
4
2003
114
0.300
Why?
GABA Agents
1
1997
1
0.290
Why?
Street Drugs
1
1997
19
0.290
Why?
Alcoholism
1
1997
96
0.270
Why?
Psychiatric Status Rating Scales
6
2005
334
0.250
Why?
Substance-Related Disorders
1
1997
206
0.240
Why?
Principal Component Analysis
2
2010
31
0.230
Why?
Disease Progression
3
2008
521
0.210
Why?
Citalopram
1
2012
1
0.210
Why?
Behavioral Symptoms
2
2000
15
0.210
Why?
Neuroimaging
1
2012
12
0.200
Why?
Phosphoric Diester Hydrolases
1
2012
55
0.200
Why?
Inositol
1
2011
25
0.200
Why?
Genetic Variation
1
2012
151
0.200
Why?
Platelet Aggregation Inhibitors
1
2011
61
0.190
Why?
Suicide
1
1997
412
0.190
Why?
Discriminant Analysis
1
2010
22
0.190
Why?
Galantamine
1
2000
1
0.190
Why?
Propylamines
1
2009
7
0.180
Why?
Brain
3
2011
1214
0.170
Why?
Adrenergic Uptake Inhibitors
1
2009
22
0.170
Why?
Spiro Compounds
1
2008
5
0.170
Why?
Prospective Studies
3
2005
1689
0.170
Why?
Diabetes Complications
1
2009
66
0.160
Why?
Brief Psychiatric Rating Scale
2
2003
13
0.160
Why?
Naproxen
1
2008
4
0.160
Why?
Quinolones
1
2008
27
0.160
Why?
Risk Factors
6
1997
2345
0.160
Why?
Follow-Up Studies
5
2006
1855
0.160
Why?
Indoles
1
2008
101
0.160
Why?
Pyrazoles
1
2008
57
0.150
Why?
Piperazines
1
2008
74
0.150
Why?
Sulfonamides
1
2008
102
0.150
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
92
0.150
Why?
Antidepressive Agents, Second-Generation
1
2006
14
0.140
Why?
Clinical Trials as Topic
3
2001
671
0.140
Why?
Caregivers
2
2003
76
0.140
Why?
Azepines
1
2006
10
0.140
Why?
Alanine
1
2006
89
0.130
Why?
Endopeptidases
1
2006
56
0.130
Why?
Placebos
4
2001
178
0.130
Why?
Psychoanalytic Interpretation
1
2005
5
0.130
Why?
Obesity
1
2009
339
0.130
Why?
Proportional Hazards Models
3
2009
450
0.120
Why?
Social Control, Formal
1
2003
10
0.120
Why?
Long-Term Care
1
2003
64
0.110
Why?
Benzodiazepines
1
2002
26
0.110
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
48
0.100
Why?
Magnetic Resonance Imaging
3
2011
991
0.100
Why?
Apolipoprotein E4
2
2009
9
0.090
Why?
Time Factors
4
2001
3182
0.090
Why?
Genotype
2
2011
490
0.090
Why?
Calcium
1
2007
1083
0.090
Why?
Statistics, Nonparametric
1
2001
262
0.090
Why?
Educational Status
2
2010
177
0.080
Why?
Regression Analysis
1
2001
527
0.080
Why?
Outcome Assessment (Health Care)
2
2011
301
0.080
Why?
Epilepsy
1
2001
165
0.080
Why?
Patient Dropouts
2
2006
26
0.080
Why?
Analysis of Variance
1
2001
736
0.080
Why?
Questionnaires
1
2003
1004
0.080
Why?
Neurotransmitter Agents
1
1997
46
0.070
Why?
Longitudinal Studies
2
2008
395
0.070
Why?
Thyroid Function Tests
1
1996
15
0.070
Why?
Reproducibility of Results
2
2010
877
0.070
Why?
Thyrotropin
1
1996
32
0.070
Why?
Cause of Death
1
1997
162
0.070
Why?
Patient Care Team
1
1997
192
0.060
Why?
Comorbidity
1
1997
380
0.060
Why?
Geriatric Assessment
2
2001
158
0.060
Why?
Randomized Controlled Trials as Topic
2
2001
411
0.060
Why?
Nursing Homes
2
2005
199
0.060
Why?
Retrospective Studies
2
2009
2267
0.060
Why?
Mood Disorders
2
2002
62
0.060
Why?
Social Support
2
2003
227
0.060
Why?
Signal Transduction
1
2002
1567
0.060
Why?
Age Factors
2
2001
1128
0.050
Why?
New York
1
1997
1305
0.050
Why?
Genome-Wide Association Study
1
2012
21
0.050
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
70
0.050
Why?
Adult
3
1996
11351
0.050
Why?
Pyridines
1
2012
75
0.050
Why?
Cognitive Therapy
1
2012
40
0.050
Why?
Genomics
1
2012
46
0.050
Why?
Electroencephalography
1
2012
176
0.050
Why?
Atrophy
1
2011
66
0.050
Why?
Polymorphism, Single Nucleotide
1
2012
90
0.050
Why?
Models, Genetic
1
2012
161
0.050
Why?
Multicenter Studies as Topic
1
2011
129
0.050
Why?
Diagnostic Imaging
1
2012
87
0.050
Why?
Adolescent
3
1996
4766
0.050
Why?
Stroop Test
1
2010
2
0.050
Why?
Word Association Tests
1
2010
4
0.050
Why?
Trail Making Test
1
2010
7
0.050
Why?
Administration, Oral
1
2011
308
0.050
Why?
Apathy
1
2010
1
0.050
Why?
Delusions
1
2010
7
0.050
Why?
Verbal Behavior
1
2010
26
0.050
Why?
Hallucinations
1
2010
14
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
462
0.050
Why?
Brain Mapping
1
2012
205
0.050
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2010
37
0.050
Why?
Reading
1
2010
22
0.050
Why?
Cross-Cultural Comparison
1
2010
33
0.050
Why?
Polymorphism, Genetic
1
2011
201
0.050
Why?
Visual Cortex
1
2012
126
0.040
Why?
Observer Variation
1
2010
144
0.040
Why?
Medication Adherence
1
2010
21
0.040
Why?
Statistics as Topic
1
2010
185
0.040
Why?
Memory
1
2010
102
0.040
Why?
PubMed
1
2009
1
0.040
Why?
Space Perception
1
2010
84
0.040
Why?
Body Weight
1
2000
327
0.040
Why?
Psychometrics
1
2010
223
0.040
Why?
Overweight
1
2009
38
0.040
Why?
Animals
2
2002
16093
0.040
Why?
Patient Compliance
1
2010
174
0.040
Why?
Drug Toxicity
1
2008
16
0.040
Why?
Chi-Square Distribution
1
2010
344
0.040
Why?
Cohort Studies
1
2012
969
0.040
Why?
Multivariate Analysis
1
2010
541
0.040
Why?
Predictive Value of Tests
1
2010
606
0.040
Why?
Confidence Intervals
1
2008
165
0.040
Why?
Body Mass Index
1
2009
218
0.040
Why?
United States
2
2003
2688
0.040
Why?
Insulin-Like Growth Factor I
1
2008
104
0.040
Why?
Saccharomyces cerevisiae
1
2012
386
0.040
Why?
Sex Factors
1
2010
597
0.040
Why?
Communication
1
2010
273
0.040
Why?
Prognosis
1
2010
1083
0.040
Why?
Glucose
1
2009
394
0.040
Why?
Problem Solving
1
2006
45
0.040
Why?
Affect
1
2006
74
0.030
Why?
Counseling
1
2006
66
0.030
Why?
Amyloid Precursor Protein Secretases
1
2006
13
0.030
Why?
Aspartic Acid Endopeptidases
1
2006
21
0.030
Why?
Outpatients
1
2005
33
0.030
Why?
Cost of Illness
1
2006
79
0.030
Why?
Quality of Life
1
2010
502
0.030
Why?
Insulin
1
2009
668
0.030
Why?
Quality Assurance, Health Care
1
2006
123
0.030
Why?
Homes for the Aged
1
2005
63
0.030
Why?
Combined Modality Therapy
1
2006
486
0.030
Why?
Primary Health Care
1
2010
487
0.030
Why?
Clinical Protocols
1
2005
106
0.030
Why?
Drug Administration Schedule
1
2005
366
0.030
Why?
Research Design
1
2006
336
0.030
Why?
Pilot Projects
1
2005
442
0.030
Why?
Ginkgo biloba
1
2003
3
0.030
Why?
Homocysteine
1
2003
28
0.030
Why?
Drug Evaluation
1
2003
101
0.030
Why?
Phytotherapy
1
2003
18
0.030
Why?
Plant Extracts
1
2003
23
0.030
Why?
Professional-Family Relations
1
2003
62
0.030
Why?
Vitamin E
1
2003
87
0.030
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2003
48
0.030
Why?
Child, Preschool
2
1996
2660
0.030
Why?
Anti-Inflammatory Agents
1
2003
110
0.030
Why?
Diagnosis, Differential
1
2005
874
0.030
Why?
Decision Making
1
2003
223
0.020
Why?
Sleep Disorders
1
2001
69
0.020
Why?
Research
1
2001
178
0.020
Why?
Child
2
1996
4155
0.020
Why?
Patient Selection
1
2001
212
0.020
Why?
Thyroxine
1
1996
46
0.020
Why?
Thyroid Diseases
1
1996
20
0.020
Why?
Triiodothyronine
1
1996
48
0.020
Why?
Cost-Benefit Analysis
1
1996
215
0.020
Why?
Infant
1
2001
2278
0.020
Why?
Mass Screening
1
1996
247
0.010
Why?
Hospitalization
1
1996
399
0.010
Why?

Visualizations


Porsteinsson's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department